About Achilles Therapeutics
Achilles Therapeutics is a company based in London (United Kingdom) founded in 2016 by Charles Swanton, Sergio Quezada, Mark Lowdell, and Karl Peggs.. Achilles Therapeutics has raised $241.98 million across 5 funding rounds from investors including Syncona, Orbimed and RA Capital. The company has 118 employees as of December 31, 2020. Achilles Therapeutics operates in a competitive market with competitors including Celgene, Caribou Biosciences, Poseida Therapeutics, Juno Therapeutics and Senti Biosciences, among others.
- Headquarter London, United Kingdom
- Employees 118 as on 31 Dec, 2020
- Founders Charles Swanton, Sergio Quezada, Mark Lowdell, Karl Peggs
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Achilles Therapeutics Plc
- Date of Incorporation 18 Nov, 2020
- Jurisdiction LONDON, UNITED KINGDOM
-
Annual Revenue
-
Net Profit
$-54.68 M (USD)-64as on Dec 31, 2019
-
EBITDA
$-64.63 M (USD)-65as on Dec 31, 2019
-
Total Equity Funding
$241.98 M (USD)
in 5 rounds
-
Latest Funding Round
$4.08 M (USD), Grant
Jul 21, 2022
-
Investors
Syncona
& 10 more
-
Employee Count
118
as on Dec 31, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Achilles Therapeutics
Achilles Therapeutics has successfully raised a total of $241.98M across 5 strategic funding rounds. The most recent funding activity was a Grant round of $4.08 million completed in July 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Grant — $4.1M
-
First Round
First Round
(24 May 2016)
- Investors Count 11
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2022 | Amount | Grant - Achilles Therapeutics | Valuation |
investors |
|
| Jun, 2021 | Amount | Grant - Achilles Therapeutics | Valuation |
investors |
|
| Nov, 2020 | Amount | Series C - Achilles Therapeutics | Valuation | Orbimed , Boxer Capital |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Achilles Therapeutics
Achilles Therapeutics has secured backing from 11 investors, including institutional and venture fund investors. Prominent investors backing the company include Syncona, Orbimed and RA Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
|
Founded Year | Domain | Location | |
|
Biotech startups are funded by this venture capital firm.
|
Founded Year | Domain | Location | |
|
Healthcare investments are managed via private equity by Syncona.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Achilles Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Achilles Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Achilles Therapeutics Comparisons
Competitors of Achilles Therapeutics
Achilles Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Celgene, Caribou Biosciences, Poseida Therapeutics, Juno Therapeutics and Senti Biosciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapies for cancer and inflammatory diseases are developed.
|
|
| domain | founded_year | HQ Location |
Provider of cell therapies to treat cancer and hematologic conditions
|
|
| domain | founded_year | HQ Location |
Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies
|
|
| domain | founded_year | HQ Location |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed.
|
|
| domain | founded_year | HQ Location |
Cell-based therapies for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
T cell-based treatments for immunological and oncological disorders are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Achilles Therapeutics
Frequently Asked Questions about Achilles Therapeutics
When was Achilles Therapeutics founded?
Achilles Therapeutics was founded in 2016.
Where is Achilles Therapeutics located?
Achilles Therapeutics is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Is Achilles Therapeutics a funded company?
Achilles Therapeutics is a funded company, having raised a total of $241.98M across 5 funding rounds to date. The company's 1st funding round was a Series C of $97.5M, raised on May 24, 2016.
How many employees does Achilles Therapeutics have?
As of Dec 31, 2020, the latest employee count at Achilles Therapeutics is 118.
What does Achilles Therapeutics do?
Achilles Therapeutics was established in 2016 in London, United Kingdom, within the biotechnology sector focused on oncology. T-cell therapies are developed to target neo-antigens, unique surface markers on cancer cells that signal the immune system. Emphasis is placed on treatments for lung cancer, recurrent metastatic melanoma, and head and neck squamous cell carcinomas. Operations involve research and therapeutic development in this specialized field.
Who are the top competitors of Achilles Therapeutics?
Achilles Therapeutics's top competitors include Immunocore, Juno Therapeutics and Senti Biosciences.
Who are Achilles Therapeutics's investors?
Achilles Therapeutics has 11 investors. Key investors include Syncona, Orbimed, RA Capital, Cancer Research UK, and European Union.
What is Achilles Therapeutics's valuation?
The valuation of Achilles Therapeutics is $165.6M as of Sep 2019.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.